Onconetix Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Onconetix Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ONCO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001782107
Board of directors
-
Ajit Singh · DirectorSince 2024
-
Andrew John Oakley · DirectorSince 2025
-
James Sapirstein · DirectorSince 2023
-
Joseph Hernandez · Director · CEOSince 2023
-
Neil J. Campbell · Director · Chief Executive OfficerSince 2023
-
Sammy Dorf · DirectorSince 2026
-
Sarah Romano · DirectorSince 2025
-
Simon Tarsh · DirectorSince 2023
-
Thomas Meier · DirectorSince 2024
-
Timothy R. Ramdeen · DirectorSince 2023
-
Vuk Jeremic · DirectorSince 2023
Chief executives
Neil J. Campbell
· Chief Executive Officer
Since October 2023
Joseph Hernandez
· CEO
Until October 2023
· Former
Board connections
6 of this board's directors also sit on 8 other boards.
- via James Sapirstein and Timothy R. Ramdeen
- via Andrew John Oakley and Timothy R. Ramdeen
- via Vuk Jeremic
- via Joseph Hernandez
- via Joseph Hernandez
- via James Sapirstein
- via Vuk Jeremic
- via Sammy Dorf
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $152,875
- 3 purchases by 1 insider
- Sold, last 12 months
- $144,469
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −49,710 | $0.69 | $34,300 |
| Apr 20, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −94,462 | $0.75 | $70,847 |
| Apr 17, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +34,636 | $0.73 | $25,284 |
| Apr 16, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −53,867 | $0.73 | $39,323 |
| Apr 15, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +92,554 | $0.76 | $70,341 |
| Apr 14, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +74,350 | $0.77 | $57,250 |
| Aug 15, 2025 | Andrew John Oakley Director | Other | +20 | — | — |
| Aug 15, 2025 | Simon Tarsh Director | Other | +39 | — | — |
| Aug 15, 2025 | Thomas Meier Director | Other | +39 | — | — |
| Aug 15, 2025 | Timothy R. Ramdeen Director | Other | +39 | — | — |
| Aug 15, 2025 | Andrew John Oakley Director | Grant or award | +618 | — | — |
| Aug 15, 2025 | Simon Tarsh Director | Grant or award | +618 | — | — |
| Aug 15, 2025 | Thomas Meier Director | Grant or award | +618 | — | — |
| Aug 15, 2025 | Timothy R. Ramdeen Director | Grant or award | +618 | — | — |
| Jul 14, 2025 | Altos Venture AG 10% owner | Other | +241,514 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.